Robert Kruklitis

534 total citations
23 papers, 423 citations indexed

About

Robert Kruklitis is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Robert Kruklitis has authored 23 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Robert Kruklitis's work include Lung Cancer Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (3 papers) and Tracheal and airway disorders (3 papers). Robert Kruklitis is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (3 papers) and Tracheal and airway disorders (3 papers). Robert Kruklitis collaborates with scholars based in United States. Robert Kruklitis's co-authors include H. Nakai, Hiroshi Nakai, Steven Μ. Albelda, Peter DeLong, Sunil Singhal, Larry R. Kaiser, Veena Kapoor, Leslie A. Litzky, Daniel H. Sterman and Mary Putt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Kruklitis

22 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Kruklitis United States 9 244 106 105 101 41 23 423
Josée Bergeron Canada 13 260 1.1× 32 0.3× 98 0.9× 102 1.0× 63 1.5× 20 525
Nina Marinsek United States 7 267 1.1× 41 0.4× 75 0.7× 43 0.4× 41 1.0× 12 449
Jung‐Sook Ha South Korea 12 207 0.8× 39 0.4× 62 0.6× 36 0.4× 19 0.5× 45 433
Ray A. Weigand United States 8 157 0.6× 105 1.0× 112 1.1× 41 0.4× 6 0.1× 13 346
Jennifer Mehalko United States 8 216 0.9× 32 0.3× 78 0.7× 29 0.3× 9 0.2× 12 444
Lucy Heinemann United Kingdom 8 160 0.7× 117 1.1× 356 3.4× 164 1.6× 10 0.2× 10 566
Jessica Lamberti Italy 10 236 1.0× 21 0.2× 55 0.5× 76 0.8× 11 0.3× 16 352
R. Schauer Germany 12 176 0.7× 45 0.4× 8 0.1× 40 0.4× 42 1.0× 21 322
Genni M Newnham Australia 5 140 0.6× 69 0.7× 29 0.3× 118 1.2× 7 0.2× 11 374
Paloma Jimena de Andrés Spain 9 103 0.4× 273 2.6× 66 0.6× 129 1.3× 6 0.1× 21 400

Countries citing papers authored by Robert Kruklitis

Since Specialization
Citations

This map shows the geographic impact of Robert Kruklitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kruklitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kruklitis more than expected).

Fields of papers citing papers by Robert Kruklitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kruklitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kruklitis. The network helps show where Robert Kruklitis may publish in the future.

Co-authorship network of co-authors of Robert Kruklitis

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kruklitis. A scholar is included among the top collaborators of Robert Kruklitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kruklitis. Robert Kruklitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kruklitis, Robert, et al.. (2022). Applications of Remote Patient Monitoring. Primary Care Clinics in Office Practice. 49(4). 543–555. 8 indexed citations
2.
Kruklitis, Robert, et al.. (2021). Key Factors Promoting Rapid Implementation of Virtual Screening Modalities for the COVID-19 Pandemic Response. The Journal of the American Board of Family Medicine. 34(Supplement). S55–S60. 7 indexed citations
3.
Greenberg, Marna Rayl, et al.. (2020). Physician‐directed smoking cessation using patient “opt‐out” approach in the emergency department: A pilot program. SHILAP Revista de lepidopterología. 1(5). 782–789. 3 indexed citations
4.
Kruklitis, Robert, et al.. (2017). Investing in New Technology in Pulmonary Medicine. CHEST Journal. 152(3). 663–671. 4 indexed citations
5.
Kruklitis, Robert, et al.. (2016). Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer. Journal of Multidisciplinary Healthcare. 9. 267–267. 32 indexed citations
6.
Kruklitis, Robert, et al.. (2015). Transient Bronchial Wall Thickening After Bronchial Thermoplasty for Asthma. Journal of Bronchology & Interventional Pulmonology. 23(1). 51–53. 3 indexed citations
7.
Kruklitis, Robert, Ilia Fishbein, Sunil Singhal, et al.. (2014). Stent-Mediated Gene Delivery for Site-Specific Transgene Administration to the Airway Epithelium and Management of Tracheobronchial Tumors. Respiration. 88(5). 406–417. 5 indexed citations
8.
Kruklitis, Robert, et al.. (2014). Clinical and Financial Considerations for Implementing an ICU Telemedicine Program. CHEST Journal. 145(6). 1392–1396. 8 indexed citations
9.
Kruklitis, Robert, et al.. (2013). Value of thoracic multidisciplinary clinic (TMDC) in determining appropriate treatment of stage III non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 31(31_suppl). 82–82. 4 indexed citations
10.
Seymour, Christopher W., William Krimsky, Jeffrey S. Sager, et al.. (2006). Transbronchial Needle Injection: A Systematic Review of a New Diagnostic and Therapeutic Paradigm. Respiration. 73(1). 78–89. 17 indexed citations
11.
12.
Tanaka, Tomoyuki, Peter DeLong, Kunjlata M. Amin, et al.. (2005). Treatment of Lung Cancer Using Clinically Relevant Oral Doses of the Cyclooxygenase-2 Inhibitor Rofecoxib. Annals of Surgery. 241(1). 168–178. 25 indexed citations
13.
Kruklitis, Robert & Daniel H. Sterman. (2004). Endobronchial Gene Therapy. Seminars in Respiratory and Critical Care Medicine. 25(4). 433–442. 2 indexed citations
14.
Kruklitis, Robert, Sunil Singhal, Peter DeLong, et al.. (2004). Immuno-gene therapy with interferon-β before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. Journal of Thoracic and Cardiovascular Surgery. 127(1). 123–130. 42 indexed citations
15.
Singhal, Sunil, Robert Kruklitis, Peter DeLong, et al.. (2003). Alterations in Cell Cycle Genes in Early Stage Lung Adenocarcinoma Identified by Expression Profiling. Cancer Biology & Therapy. 2(3). 291–298. 69 indexed citations
16.
Sterman, Daniel H., et al.. (2003). Pleurodesis for the Therapy of Malignant Pleural Effusions. Journal of Bronchology. 10(3). 218–222.
17.
Singhal, Sunil, Kunjlata M. Amin, Robert Kruklitis, et al.. (2003). Differentially Expressed Apoptotic Genes in Early Stage Lung Adenocarcinoma Predicted by Expression Profiling. Cancer Biology & Therapy. 2(5). 566–571. 13 indexed citations
18.
Kruklitis, Robert, et al.. (1996). ClpX protein of Escherichia coli activates bacteriophage Mu transposase in the strand transfer complex for initiation of Mu DNA synthesis.. The EMBO Journal. 15(4). 935–944. 106 indexed citations
19.
Nakai, Hiroshi & Robert Kruklitis. (1995). Disassembly of the Bacteriophage Mu Transposase for the Initiation of Mu DNA Replication. Journal of Biological Chemistry. 270(33). 19591–19598. 37 indexed citations
20.
Kruklitis, Robert & H. Nakai. (1994). Participation of the bacteriophage Mu A protein and host factors in the initiation of Mu DNA synthesis in vitro.. Journal of Biological Chemistry. 269(23). 16469–16477. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josée Bergeron Breakdown of academic impact, for papers by Nina Marinsek Breakdown of academic impact, for papers by Jung‐Sook Ha Breakdown of academic impact, for papers by Ray A. Weigand Breakdown of academic impact, for papers by Jennifer Mehalko Breakdown of academic impact, for papers by Lucy Heinemann Breakdown of academic impact, for papers by Jessica Lamberti Breakdown of academic impact, for papers by R. Schauer Breakdown of academic impact, for papers by Genni M Newnham Breakdown of academic impact, for papers by Paloma Jimena de Andrés
Rankless by CCL
2026